Home › Non-Small Cell Lung Cancer › New Jersey › Clifton
Non-Small Cell Lung Cancer clinical trials in Clifton, NJ
24 studies for Non-Small Cell Lung Cancer are looking for participants at sites in and around Clifton (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of ZW251 in Participants With Advanced Solid Tumors
RecruitingPhase 1
- Hackensack University Medical Center, Hackensack · 7 mi away
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
RecruitingPhase 1
- Exelixis Clinical Site #105, Hackensack · 7 mi away
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
RecruitingPhase 3
- John Theurer Cancer Center at Hackensack University Medical Center ( Site 0152), Hackensack · 7 mi away
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
RecruitingPhase 3
- John Theurer Cancer Center at Hackensack UMC, Hackensack · 7 mi away
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
RecruitingPhase 2
- Hackensack University Medical Center, Hackensack · 7 mi away
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
RecruitingPhase 1/2
- Hackensack University Medical Center, Hackensack · 7 mi away
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi away
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
RecruitingPhase 1/2
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi away
A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)
RecruitingPhase 1
- Hackensack University Medical Center, Hackensack · 7 mi away
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
RecruitingPhase 1/2
- Hackensack University Medical Center, Hackensack · 7 mi away
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
RecruitingPhase 1/2
- Hackensack University Medical Center, Hackensack · 7 mi away
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
RecruitingPhase 2/3
- John Theurer Cancer Center, Hackensack · 7 mi away
Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
RecruitingPhase 2
- Hackensack Meridian Health, Hackensack · 7 mi away
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
RecruitingPhase 3
- John Theurer Cancer Center at Hackensack University Medical Center ( Site 0035), Hackensack · 7 mi away
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
RecruitingPhase 1/2
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi away
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
RecruitingPhase 1/2
- John Theurer Cancer Center at Hackensack UMC, Hackensack · 7 mi away
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
RecruitingPhase 1
- John Theurer Cancer Ctr at Hackensack Univ. Med Ctr., Hackensack · 7 mi away
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
RecruitingPhase 1/2
- John Theurer Cancer Center, Hackensack · 7 mi away
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
RecruitingPhase 1
- Hackensack University Medical Center - John Theurer Cancer Center, Hackensack · 7 mi away
A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors
RecruitingPhase 1
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi away
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
RecruitingPhase 1
- Hackensack University Medical Center, Hackensack · 7 mi away
A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.
RecruitingPhase 1
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi away
A Study of LY4175408 in Participants With Advanced Cancer
RecruitingPhase 1
- John Theurer Cancer Center At Hackensack UMC, Hackensack · 7 mi away
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
RecruitingPhase 1
- Hackensack University Medical Center, Hackensack · 7 mi away
RAPA-201 Therapy of Solid Tumors
RecruitingPhase 1/2
- Hackensack University Medical Center, Hackensack · 7 mi away
Non-Small Cell Lung Cancer trials in other cities
- Houston, TX145 studies
- New York City, NY121 studies
- Arlington, VA104 studies
- Nashville, TN97 studies
- Boston, MA90 studies
- Los Angeles, CA87 studies
- St. Louis, MO73 studies
- Chicago, IL61 studies
- Baltimore, MD60 studies
- San Antonio, TX59 studies
- Columbus, OH57 studies
- Washington, DC55 studies
Other studies in Clifton
- Cancer (all types)15 studies
- Multiple Myeloma14 studies
- Metastatic Cancer12 studies
- Acute Myeloid Leukemia12 studies
- Breast Cancer12 studies
- Prostate Cancer12 studies
- Ovarian Cancer11 studies
- Lung Cancer10 studies
- Colorectal Cancer8 studies
- Head and Neck Squamous Cell Carcinoma8 studies
- Endometrial Cancer8 studies
- Heart Failure8 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.